Lykos Therapeutics Strengthens Commercial Organization with Key Hires as it Prepares for Potential Commercial Launch

Allison Rosenthal appointed Chief Commercial Officer to lead the potential commercial launch of MDMA-assisted therapy if approved by the FDA Coy Stout joins as Vice President of Market Access SAN JOSE, Calif., May 3, 2024 /PRNewswire/ — Lykos Therapeutics (“Lykos”), a company dedicated…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks